[1] Bonner JA,Harari PM,Giralt J,et al. Radiotherapy plus Cetuximab for squamous-cell carcinoma of the head and neck[J]. N Eng J Med,2006,354(6):567-578. [2] Perez-Vargas JCS,Biondani P,Maggi C,et al. Role of cMet in the development and progression of colorectal cancer[J]. Int J Mol Sci,2013,14(9):18056-18077.DOI:10.3390/ijms140918056. [3] Gherardi E,Birchmeier W,Birchmeier C,et al. Targeting MET in cancer:rationale and progress[J]. Nat Rev Cancer,2012,12(2):89-103.DOI:10.1038/nrc3205. [4] Blumenschein Jr GR,Mills GB,Gonzalez-Angulo AM. Targeting the hepatocyte growth factor-cMET axis in cancer therapy[J]. J Clin Oncol,2012,30(26):3287-3296.DOI:10.1200/JCO.2011.40.3774. [5] Preusser M,Streubel B,Berghoff AS,et al. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer[J]. Histopath,2014,65(5):684-692.DOI:10.1111/his.12475. [6] Zhang YW,Su Y,Volpert OV,et al. Hepatocyte growth factor scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin l regulation[J]. Proc Natl Acad Sci USA,2003,100(22):12718-12723. [7] Kim KJ,Wang L,Su Y,et al Systematic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma[J]. Clin Cancer Res,2006,12(4):1292-1298. [8] Hu SY,Duan HF,Li QF,et al. Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage[J]. Acta Pharmacologica Sinica,2009,30(10):1415-1420.DOI:10.1038/aps.2009.133. [9] Aebersold DM,Kollar A,Beer KT,et al. Involvement of the hepatocyte growth/scatter factor receptor c-met and of Bcl-xL in the resistance of oropharyngeal cancer to ionizing radiation[J]. Int J Cancer,2001,96(1):41-54. [10] Kim YJ,Go H,Wu HG,et al. Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy[J]. Head Neck,2011,33(10):1458-1466.DOI:10.1002/hed.21611. [11] Raghav KP,Wang W,Liu S,et al. cMET and phospho-cMET protein levels in breast cancers and survival outcomes[J]. Clin Cancer Res,2012,18(8):2269-2277.DOI:10.1158/1078-0432.CCR-11-2830. [12] Aebersold DM,Landt O,Berthou S,et al. Prevalence and clincal impact of MET Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx[J]. Oncogene,2003,22(52):8519-8523. [13] De Bacco F,Luraghi P,Medico E,et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer[J]. J Natl Cancer Inst,2011,103(8):645-661.DOI:10.1093/jnci/djr093. [14] Medova M,Aebersold DM,Zimmer Y. The molecular crosstalk between the MET receptor tyrosine kinase and the DNA damage response-biological and clinical aspects[J]. Cancers,2013,6(1):1-27.DOI:10.3390/cancers6010001. [15] Hellevik T,Pettersen I,Berg V,et al. Changes in the secretory profiles of NSCLC-associated fibroblasts after ablative radiotherapy:potential impact on angiogenesis and tumor growth[J].Translational Oncol,2013,6(1):66-74. [16] Ohuchida K,Mizumoto K,Murakami M,et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions[J]. Cancer Res,2004(9),64:3215-3222. [17] Bhardwaj V,Cascone T,Cortez MA,et al. Modulation of c-Met signalling and cellular sensitivity to radiation:potential implications for therapy[J]. Cancer,2013,119(10):1768-1775.DOI:10.1002/cncr.27965. [18] Liu Y,Qi-Feng S,Qi M,et al.Interruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer a549 cells via c-Met-nuclear factor-κB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathways[J].Biol Pharm Bull,2012,35(7):1150-1158. [19] Buchanan IM,Scott T,Tandle AT,et al. Radiosensitization of glioma cells by modulation of Met signaling with the hepatocyte growth factor neutralizing antibody,AMG102[J]. J Cell Mol Med,2011,15(9):1999-2006.DOI:10.1111/j.1582-4934.2010.01122.x. [20] Yang H,Lee HW,Kim Y,et al. Radiosensitization of brain metastasis by targeting c-MET[J]. Lab Investigation,2013,93(3):344-353.DOI:10.1038/labinvest.2012.180. [21] Li B,Torossian A,Sun Y,et al. Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458,a novel selective c-Met inhibitor with radiosensitizing effects[J]. Int J Radiat Oncol Biol Phys,2012,84(4):525-531.DOI:10.1016/j.ijrobp.2012.06.025.
2015, Vol. 24 
